serena williams opens up about being on a glp 1 GLP-1 Serena Williams Discusses GLP-1 Journey

As of 2025, retatrutide remains an investigational medicine and is not yet approved for clinical use in the United Kingdom

Treatment Expectations Patients should understand: Expected outcomes may vary Treatment requires ongoing clinical monitoring Lifestyle factors such as nutrition and activity remain important Potential Risks and Side Effects Patients should be informed about possible side effects, including: Common gastrointestinal effects Potential serious risks Interactions with other medications Off-Label and Compounded Use Disclosure A key consent component is disclosure that compounded prescriptions may differ from commercially manufactured drugs and may be prescribed in cases where individualized dosing or formulation is needed

This once-weekly injection represents the potential future of metabolic medicine

Incretins are gut-derived hormones, members of the glucagon superfamily

doi: 10.1136/bmj.d7771

They may also adjust the dosage if needed